Sio Gene Therapies, Inc. (SIOX) Social Stream



Sio Gene Therapies, Inc. (SIOX): $0.29

0.02 (+8.83%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add SIOX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 416

in industry

Sio Gene Therapies Inc (SIOX) Price Targets From Analysts

Use the tables below to see what analysts covering Sio Gene Therapies Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-15 5 $12.5 $6 $8.583 $0.705 1117.45%
2022-02-01 5 $12.5 $1 $6.416 $0.705 810.07%
2022-02-11 5 $12.5 $1 $6.3 $0.705 793.62%
2022-02-14 5 $12.5 $1 $6.2 $0.705 779.43%

The Trend in the Analyst Price Target


Over the past 32 weeks, SIOX's average price target has gone down $2.22.

Over the past 44 weeks, SIOX's average upside potential has been 325.35%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-17 4 12.5 7 8.880 2.45 262.45%
2021-08-01 4 12.5 7 8.420 2.04 312.75%
2021-09-19 4 8.0 6 7.400 2.22 233.33%
2021-10-21 5 12.5 6 8.583 2.36 263.69%
2021-11-15 5 12.5 6 8.583 1.87 358.98%

SIOX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.4 4 0 1 0 0 5

The Trend in the Broker Recommendations


Over the past 13 months, SIOX's average broker recommendation rating improved by 0.43.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SIOX as an investment opportunity.

  • Sio Gene Therapies Inc's upside potential (average analyst target price relative to current price) is higher than 394.2% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, Sio Gene Therapies Inc's variance in analysts' estimates is lower than -282.02% of them.
  • Sio Gene Therapies Inc's average analyst price target is greater than 13.26% of stocks in the mid market cap category.
  • In the context of stocks in the mid market cap category, Sio Gene Therapies Inc's number of analysts covering the stock is higher than 102.52% of them.

Stocks similar to Sio Gene Therapies Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are SDGR, SAVA, and SAGE.

Is SIOX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.3976 seconds.